Alchemab Therapeutics

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.

AbCellera

This company develops antibody discovery technology and therapeutic medicines for biotechnology and pharmaceutical partners to treat cancer, autoimmune disorders and infectious diseases.

Aliada Therapeutics

This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.

AbCellera Biologics

The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.

Re-Aim Therapeutics

This early-stage biotechnology company develops antibody-based therapies that target and deplete disease-causing cells to treat patients with autoimmune and inflammatory disorders.

Mestag Therapeutics

This company develops antibody therapies targeting fibroblast immunology for patients with cancer and inflammatory diseases.

Xaira

The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.